Skip to main content
Equibles
ADUS logo

ADUS · Addus HomeCare Corp · Metrics

Track ADUS — free

Use ADUS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ADUS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$124.60 +2.42 (+1.98%) Q2 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.28B
Shares
18.67M
Volume · Oct 29 51.41K Avg daily vol (3M) 206.06K

ADUS metrics

99 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$122.18
Market cap
$2.28B

Price action

20 metrics
Price change (1W)
+3.6%
Price change (30D)
+8.2%
Price change (3M)
+2.6%
Price change (6M)
+26.0%
Price change (YTD)
+13.8%
Price change (1Y)
+1.4%
Trailing year
Price change (5Y)
+39.7%
52-week high
$122.75
52-week low
$88.49
Change from 52-week high
-0.5%
Change from 52-week low
+38.1%
Annualized volatility
29.0%
Annualized volatility (3M)
21.6%
Beta
0.2
RSI (14D)
66.7
Price vs SMA 50
+4.6%
Price vs SMA 200
+15.0%
Avg volume (3M)
206,058
Relative volume
1.5
Average dollar volume
$24.08M

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
18.67M

Valuation

12 metrics
P / E (TTM)
21.4
Trailing earnings · reciprocal yield 4.7%
PEG ratio
0.9
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.5×
reciprocal yield 64.7%
P / book
2.0
reciprocal yield 50.3%
FCF yield
6.8%
TTM · current market cap
Buyback yield
—
P / FCF
14.7
reciprocal yield 6.8%
P / operating cash flow
14.0
reciprocal yield 7.1%
Earnings yield
4.6%

Historical valuation

8 metrics
P / E historical average (3Y)
23.8×
reciprocal yield 4.2%
P / E historical average (5Y)
28.1×
reciprocal yield 3.6%
EV / revenue historical average (3Y)
1.7×
reciprocal yield 59.0%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 55.5%
EV / EBIT historical average (3Y)
21.2×
reciprocal yield 4.7%
EV / EBIT historical average (5Y)
25.1×
reciprocal yield 4.0%
EV / EBITDA historical average (3Y)
17.9×
reciprocal yield 5.6%
EV / EBITDA historical average (5Y)
20.6×
reciprocal yield 4.9%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
32.4%
Operating margin
10.0%
Trailing 12 months
Net margin
7.1%
Gross profit (TTM)
$477.75M
Operating profit (TTM)
$148.23M
Net income (TTM)
$105.31M
Trailing 12 months
Diluted EPS (TTM)
$5.71
FCF margin
10.5%
Effective tax rate
25.2%

Per share

11 metrics
Revenue per diluted share (TTM)
$79.94
Gross profit per diluted share (TTM)
$25.87
Operating profit per diluted share (TTM)
$8.02
EBITDA per diluted share (TTM)
$8.93
Net income per diluted share (TTM)
$5.70
Operating cash flow per diluted share (TTM)
$8.80
Free cash flow per diluted share (TTM)
$8.39
Capital expenditures per diluted share (TTM)
$0.41
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
$0.99
Book value per share
$58.21

Growth

11 metrics
Revenue growth YoY
+8.0%
Year over year
Net income growth YoY
+25.2%
Revenue (TTM)
$1.48B
Trailing 12 months
EPS growth YoY
+24.2%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+14.4%
Revenue CAGR (5Y)
+13.2%
EPS CAGR (3Y)
+22.5%
EPS CAGR (5Y)
+20.2%
FCF CAGR (3Y)
+2.3%
FCF CAGR (5Y)
+0.2%

Quality

14 metrics
Return on equity
9.2%
Return on assets
7.2%
Debt / equity
0.1
Current ratio
1.7
EBITDA (TTM)
$164.94M
Free cash flow (TTM)
$154.77M
Quick ratio
1.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$119.53M
Latest balance sheet
Cash & equivalents
$96.95M
Total assets
$1.46B
Total debt
$61.60M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$162.41M
Capital expenditures (TTM)
$7.63M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$18.22M
R&D / revenue
—
Stock compensation / revenue
1.2%

Ownership (13F)

9 metrics
13F filers
304
13F filer change QoQ
+6
Institutional ownership
104.1%
Conviction holders (share of 13F filers)
0.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-1.1%
Holder tenure
15.6
Price vs estimated holder cost
-4.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
24.5%

Short interest

3 metrics
Short interest
4.1%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1468328 CUSIP 006739106 13F (30d) 67 filings 67 filers Visit website Investor relations